drugset / Trial / NCT02351310
Effectiveness of ACS in Extreme Preemies
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized prospective clinical study that will evaluate the effects of antenatal corticosteroid administration (ACS) vs. placebo in singleton pregnancies who are threatening to deliver prematurely between 22 0/7 and 23 6/7 weeks on admission with the goal of improving composite neonatal mortality and morbidity.
Timeline
- Start
- 2015-11
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betamethasone | Other / unclassified | 12 mg | Intramuscular |
Indications
No indication recorded.